Skip to main content
DBD
NYSE Technology

Millstreet Capital Management Sells $49.9M of Diebold Nixdorf Shares, Reducing Stake

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
7
Price
$68.61
Mkt Cap
$2.461B
52W Low
$34.875
52W High
$72.295
Market data snapshot near publication time

summarizeSummary

Millstreet Capital Management, a significant institutional investor, reported selling approximately $49.9 million worth of Diebold Nixdorf common shares across three transactions, reducing its ownership stake.


check_boxKey Events

  • Significant Share Sales

    Millstreet Capital Management LLC, along with associated reporting persons, sold a total of 751,726 common shares of Diebold Nixdorf across three open market transactions.

  • Total Value of Sales

    The reported sales amounted to approximately $49.9 million, with transactions occurring on November 5, 2025 ($13.3M), November 6, 2025 ($2.6M), and January 15, 2026 ($34.0M).

  • Reduced Ownership Stake

    Following these sales, Millstreet Capital Management's aggregate ownership in Diebold Nixdorf stands at 5,216,672 shares, representing 14.54% of the class outstanding.


auto_awesomeAnalysis

Millstreet Capital Management, a major institutional investor, has significantly reduced its position in Diebold Nixdorf through a series of open market sales totaling approximately $49.9 million. These transactions, which occurred between November 2025 and January 2026, saw the firm divest 751,726 shares. While Millstreet Capital Management remains a substantial shareholder with a 14.54% stake, this reduction in holdings by a key institutional investor could be interpreted as a shift in sentiment or a portfolio rebalancing, potentially signaling a less bullish outlook on the company's near-term prospects.

At the time of this filing, DBD was trading at $68.61 on NYSE in the Technology sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $34.88 to $72.30. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed DBD - Latest Insights

DBD
Apr 17, 2026, 4:28 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
DBD
Apr 10, 2026, 4:04 PM EDT
Filing Type: 4
Importance Score:
7
DBD
Feb 12, 2026, 4:38 PM EST
Filing Type: 10-K
Importance Score:
9
DBD
Feb 12, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
8
DBD
Jan 20, 2026, 4:11 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
DBD
Jan 20, 2026, 4:10 PM EST
Filing Type: 4
Importance Score:
7
DBD
Jan 15, 2026, 4:40 PM EST
Filing Type: 144
Importance Score:
7